These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22484034)

  • 1. PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport.
    Wan HT; Zhao YG; Wei X; Hui KY; Giesy JP; Wong CK
    Biochim Biophys Acta; 2012 Jul; 1820(7):1092-101. PubMed ID: 22484034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic perfluorooctane sulfonate (PFOS) exposure induces hepatic steatosis in zebrafish.
    Cheng J; Lv S; Nie S; Liu J; Tong S; Kang N; Xiao Y; Dong Q; Huang C; Yang D
    Aquat Toxicol; 2016 Jul; 176():45-52. PubMed ID: 27108203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prenatal PFOS exposure on liver cell function in neonatal mice.
    Liang X; Xie G; Wu X; Su M; Yang B
    Environ Sci Pollut Res Int; 2019 Jun; 26(18):18240-18246. PubMed ID: 31041707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice.
    Bijland S; Rensen PC; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; Havekes LM; Willems van Dijk K; Chang SC; Ehresman DJ; Butenhoff JL; Princen HM
    Toxicol Sci; 2011 Sep; 123(1):290-303. PubMed ID: 21705711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline Supplementation.
    Bagley BD; Chang SC; Ehresman DJ; Eveland A; Zitzow JD; Parker GA; Peters JM; Wallace KB; Butenhoff JL
    Toxicol Sci; 2017 Dec; 160(2):284-298. PubMed ID: 28973659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression.
    Bjork JA; Lau C; Chang SC; Butenhoff JL; Wallace KB
    Toxicology; 2008 Sep; 251(1-3):8-20. PubMed ID: 18692542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis and CYP4A1 expression in Sprague-Dawley rats exposed to low doses of perfluorooctane sulfonate.
    Kim HS; Jun Kwack S; Sik Han E; Seok Kang T; Hee Kim S; Young Han S
    J Toxicol Sci; 2011 Apr; 36(2):201-10. PubMed ID: 21467747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver disease induced by perfluorooctane sulfonate: Novel insight from transcriptome analysis.
    Fai Tse WK; Li JW; Kwan Tse AC; Chan TF; Hin Ho JC; Sun Wu RS; Chu Wong CK; Lai KP
    Chemosphere; 2016 Sep; 159():166-177. PubMed ID: 27289203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.
    Thibodeaux JR; Hanson RG; Rogers JM; Grey BE; Barbee BD; Richards JH; Butenhoff JL; Stevenson LA; Lau C
    Toxicol Sci; 2003 Aug; 74(2):369-81. PubMed ID: 12773773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editor's Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in Mice.
    Zhang L; Krishnan P; Ehresman DJ; Smith PB; Dutta M; Bagley BD; Chang SC; Butenhoff JL; Patterson AD; Peters JM
    Toxicol Sci; 2016 Sep; 153(1):186-97. PubMed ID: 27413108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system.
    Yu WG; Liu W; Jin YH; Liu XH; Wang FQ; Liu L; Nakayama SF
    Environ Sci Technol; 2009 Nov; 43(21):8416-22. PubMed ID: 19924978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS).
    Curran I; Hierlihy SL; Liston V; Pantazopoulos P; Nunnikhoven A; Tittlemier S; Barker M; Trick K; Bondy G
    J Toxicol Environ Health A; 2008; 71(23):1526-41. PubMed ID: 18923995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.
    Cwinn MA; Jones SP; Kennedy SW
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Aug; 148(2):165-71. PubMed ID: 18565798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of perfluorooctanesulfonic acid (PFOS) on the liver lipid metabolism of the developing chicken embryo.
    Geng D; Musse AA; Wigh V; Carlsson C; Engwall M; Orešič M; Scherbak N; Hyötyläinen T
    Ecotoxicol Environ Saf; 2019 Apr; 170():691-698. PubMed ID: 30580163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
    Bjork JA; Butenhoff JL; Wallace KB
    Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism.
    Yu WG; Liu W; Jin YH
    Environ Toxicol Chem; 2009 May; 28(5):990-6. PubMed ID: 19045937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice.
    Marques E; Pfohl M; Auclair A; Jamwal R; Barlock BJ; Sammoura FM; Goedken M; Akhlaghi F; Slitt AL
    Toxicol Appl Pharmacol; 2020 Dec; 408():115250. PubMed ID: 32979393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global liver proteome analysis using iTRAQ labeling quantitative proteomic technology to reveal biomarkers in mice exposed to perfluorooctane sulfonate (PFOS).
    Tan F; Jin Y; Liu W; Quan X; Chen J; Liang Z
    Environ Sci Technol; 2012 Nov; 46(21):12170-7. PubMed ID: 23046066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.